SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on lupus and scleroderma
Disease control OngoingThis study tests a new treatment using donor immune cells (CAR T-cells) that are designed to target and destroy faulty immune cells causing lupus and scleroderma. The goal is to control these severe autoimmune diseases when other treatments have failed. 18 adults with relapsed or…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: NA • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Apr 28, 2026 21:35 UTC
-
New pill could tame lupus flares without needles
Disease control OngoingThis study tests an oral medication called deucravacitinib against a placebo in about 513 people with active moderate-to-severe lupus. The goal is to see if the drug can reduce disease activity and improve symptoms like joint pain and skin rashes. Participants must have been diag…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Apr 28, 2026 13:14 UTC